首页 | 本学科首页   官方微博 | 高级检索  
     


Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized,placebo‐controlled phase II study
Authors:S. Fukudo  K. Matsueda  K. Haruma  M. Ida  H. Hayase  H. Akiho  Y. Nakashima  M. Hongo
Affiliation:1. Department of Behavioral Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan;2. Sakura Life Clinic, Tokyo, Japan;3. Department of Gastroenterology, Kawasaki Medical University, Kurashiki, Japan;4. Japan‐Asia Planning & Administration, Medical & Development, Astellas Pharma Inc., Tokyo, Japan;5. Japan‐Asia Clinical Development 2, Development, Astellas Pharma Inc., Tokyo, Japan;6. Japan‐Asia Data Science, Development, Astellas Pharma Inc., Tokyo, Japan;7. Kurokawa Hospital, Miyagi, Japan
Abstract:
Keywords:5‐hydroxytryptamine  abdominal discomfort  abdominal pain  global improvement  stool consistency
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号